Carboplatin Clinical Trials

• Phase II Trial of Gemcitabine and Carboplatin Followed by Paclitaxel and Carboplatin With Radiation for Stage IIIA/IIIB NSCLC.
  ClinicalTrials.gov Identifier: NCT00226590 - Active, not recruiting
  Carcinoma, Non-Small-Cell Lung
  
• MITO-2: A Study Comparing 2 Chemotherapy Regimens (Carboplatin/Liposomal Doxorubicin vs Carboplatin/Paclitaxel) in Patients With Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00326456 - Active, not recruiting
  Ovarian Cancer
  
• Caelyx Plus Carboplatin Versus Paclitaxel Plus Carboplatin in Patients With Epithelial Ovarian Cancer in Late Relapse
  ClinicalTrials.gov Identifier: NCT00189553 - Active, not recruiting
  Ovarian Cancer; Fallopian Tube Cancer
  
• BMS-188797 and Carboplatin in Treating Patients With Advanced Nonhematologic Cancer
  ClinicalTrials.gov Identifier: NCT00006086 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Multi-National, Randomized, Phase III, GCIG Intergroup Study Comparing Pegylated Liposomal Doxorubicin (CAELYX) and Carboplatin vs. Paclitaxel and Carboplatin in Patients With Epithelial Ovarian Cancer in Late Relapse. (CALYPSO)
  ClinicalTrials.gov Identifier: NCT00538603 - Active, not recruiting
  Epithelial Ovarian Cancer
  
• Fludarabine, Carboplatin, and Topotecan in Treating Patients With Relapsed or Refractory Acute Leukemia or Advanced Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00005593 - Active, not recruiting
  Leukemia
  
• Comparison of Paclitaxel/Carboplatin and Lonafarnib to Paclitaxel/Carboplatin for First-Line Treatment of Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00281515 - Active, not recruiting
  Epithelial Ovarian Cancer
  
• Trial of Paclitaxel/Carboplatin + PF-3512676 vs Paclitaxel/Carboplatin Alone in Patients With Advanced Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00254891 - Active, not recruiting
  Carcinoma, Non-Small-Cell Lung
  
• Osteosarcoma1999-A Study Of Intensive Chemotherapy Utilizing Ifosfamide, Carboplatin, and Doxorubicin for Adjuvant Chemotherapy For Treatment Of Osteosarcoma
  ClinicalTrials.gov Identifier: NCT00145639 - Active, not recruiting
  Osteosarcoma
  
• CT-2103/Carboplatin vs Paclitaxel/Carboplatin for NSCLC in Women With Normal Estradiol
  ClinicalTrials.gov Identifier: NCT00576225 - Recruiting
  NSCLC
  
• Determination of Carboplatin''s Optimal Plasmatic Exposure
  ClinicalTrials.gov Identifier: NCT00145028 - Recruiting
  Neoplasms
  
• Carboplatin Plus Vincristine in Treating Children With Retinoblastoma
  ClinicalTrials.gov Identifier: NCT00002794 - Active, not recruiting
  intraocular retinoblastoma
  
• Paclitaxel, Carboplatin and Gemcitabine in the Treatment of Patients with Advanced Transitional Cell Cancer of the Bladder
  ClinicalTrials.gov Identifier: NCT00136175 - Active, not recruiting
  Bladder Cancer
  
• Study of Pemetrexed and Carboplatin Compared With Etoposide Carboplatin to Treat Extensive-Stage Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00363415 - Recruiting
  Carcinoma, Small Cell
  
• Carboplatin Plus Paclitaxel With or Without Continued Low-Dose Paclitaxel in Treating Patients With Early-Stage Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00003644 - Active, not recruiting
  ovarian epithelial cancer
  
• Carboplatin Plus Irinotecan in Treating Patients With Glioblastoma Multiforme
  ClinicalTrials.gov Identifier: NCT00010036 - Active, not recruiting
  adult glioblastoma multiforme
  
• Erlotinib (Tarceva) vs. Standard Chemotherapy (Paclitaxel and Carboplatin) in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) and ECOG PS 2
  ClinicalTrials.gov Identifier: NCT00085839 - Active, not recruiting
  Non-Small Cell Lung Carcinoma
  
• A Study of Paclitaxel/Carboplatin With or Without CDP791 in Patients with Lung Cancer
  ClinicalTrials.gov Identifier: NCT00152477 - Active, not recruiting
  Carcinoma, Non-Small-Cell Lung
  
• Systemic Vincristine, Carboplatin, and Etoposide, Subtenon Carboplatin, and Local Ophthalmic Therapy With or Without Low-Dose Radiation Therapy in Treating Children With Intraocular Retinoblastoma
  ClinicalTrials.gov Identifier: NCT00072384 - Recruiting
  intraocular retinoblastoma
  
• Carboplatin and Temozolomide in Treating Patients With Unresectable or Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00003747 - Active, not recruiting
  Stage IV Melanoma; Recurrent Melanoma
  
• Calcitriol Plus Carboplatin in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00008086 - Active, not recruiting
  Brain Tumor; Genetic Condition; Solid Tumor
  
• Carboplatin and Irinotecan in Treating Children With Refractory Solid Tumors
  ClinicalTrials.gov Identifier: NCT00024284 - Active, not recruiting
  unspecified childhood solid tumor, protocol specific
  
• Carboplatin With or Without Gemcitabine in Treating Patients With Advanced Ovarian Epithelial Cancer That Has Not Responded to Previous Chemotherapy
  ClinicalTrials.gov Identifier: NCT00006453 - Active, not recruiting
  recurrent ovarian epithelial cancer
  
• Phase II CT-2103/Carboplatin in Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00069901 - Active, not recruiting
  Ovarian Neoplasm
  
• Cisplatin-Epinephrine Injectable Gel Plus Paclitaxel and Carboplatin in Treating Patients With Recurrent Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00022217 - Active, not recruiting
  Nose Cancer; Oral Cancer; Throat Cancer
  
• A Study of Docetaxel Plus Carboplatin in Patients with Hormone Refractory Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00134706 - Active, not recruiting
  Prostate Cancer; Cancer of the Prostate; Cancer of Prostate
  
• Phase I Study of Carboplatin and Gemcitabine in Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00021346 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Docetaxel and Carboplatin in Treating Women With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00005963 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Paclitaxel With or Without Carboplatin in Treating Women With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00025688 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Carboplatin, Paclitaxel, and Bevacizumab in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00255762 - Active, not recruiting
  Recurrent Melanoma; Stage IV Melanoma
  
• Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Unresectable, Metastatic Cancer of the Esophagus or Gastroesophageal Junction
  ClinicalTrials.gov Identifier: NCT00107341 - Active, not recruiting
  Adenocarcinoma of the Esophagus; stage IV esophageal cancer; recurrent esophageal cancer
  
• Polyglutamate Paclitaxel Plus Carboplatin Compared With Paclitaxel Plus Carboplatin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00054210 - Active, not recruiting
  recurrent non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer
  
• Carboplatin Taxol Avastin in OVCA
  ClinicalTrials.gov Identifier: NCT00129727 - Recruiting
  Ovarian Cancer
  
• Irinotecan and Carboplatin in Treating Patients With Newly Diagnosed Extensive-Stage Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00104793 - Active, not recruiting
  extensive stage small cell lung cancer
  
• Calcitriol and Carboplatin in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00017576 - Active, not recruiting
  stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer
  
• Cetuximab and Carboplatin in Treating Patients With Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00086892 - Active, not recruiting
  recurrent ovarian epithelial cancer; peritoneal cavity cancer
  
• Trastuzumab, Ixabepilone, and Carboplatin in Treating Patients With HER2/neu-Positive Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00077376 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer; Male Breast Cancer
  
• Gemcitabine/Oxaliplatin (GEMOX) vs Carboplatin/Paclitaxel (CP) in Non-small Cell Lung Cancer (NSCLC)
  ClinicalTrials.gov Identifier: NCT00087802 - Active, not recruiting
  Carcinoma, Non-Small-Cell Lung
  
• Study of Pemetrexed + Carboplatin + Bevacizumab + Enzastaurin Versus Pemetrexed + Carboplatin + Bevacizumab + Placebo in Patients With Non-Small Cell Lung Cancer Who Have Not Been Previously Treated With Chemotherapy
  ClinicalTrials.gov Identifier: NCT00533429 - Recruiting
  Non-Small Cell Lung Cancer
  
• Trastuzumab (Herceptin), Paclitaxel, Carboplatin and Gemcitabine in Advanced Urothelial Cancer
  ClinicalTrials.gov Identifier: NCT00151034 - Active, not recruiting
  Advanced Urothelial Cancer
  
• Paclitaxel and Carboplatin With or Without Celecoxib Before Surgery in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00062179 - Active, not recruiting
  stage IIIA non-small cell lung cancer
  
• Weekly Topotecan in Combination With Carboplatin in Two Different Schedules for Refractory and/or Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00193583 - Active, not recruiting
  Cancer
  
• First Line IRESSA™ Versus Carboplatin/Paclitaxel in Asia
  ClinicalTrials.gov Identifier: NCT00322452 - Active, not recruiting
  Non-Small Cell Lung Cancer
  
• Paclitaxel, Carboplatin, and Radiation Therapy With or Without Adjuvant Paclitaxel and Carboplatin in Treating Patients With Stage II or Stage III Unresectable Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00077220 - Active, not recruiting
  stage II non-small cell lung cancer; stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer
  
• Liposomal Doxorubicin and Carboplatin in Treating Patients With Gynecologic Cancer
  ClinicalTrials.gov Identifier: NCT00032162 - Active, not recruiting
  Cervical Cancer; Endometrial Cancer; Fallopian Tube Cancer; uterine sarcoma; ovarian sarcoma; ovarian carcinosarcoma
  
• Pemetrexed Disodium and Either Cisplatin or Carboplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00062088 - Active, not recruiting
  extensive stage small cell lung cancer
  
• Neoadjuvant Carboplatin and Vincristine and Standard Local Ophthalmic Therapy in Treating Patients With Intraocular Retinoblastoma
  ClinicalTrials.gov Identifier: NCT00079417 - Recruiting
  intraocular retinoblastoma
  
• Docetaxel Plus Carboplatin in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00003560 - Active, not recruiting
  Endometrial Cancer; Fallopian Tube Cancer; ovarian epithelial cancer; peritoneal cavity cancer
  
• Topotecan Plus Paclitaxel and Carboplatin in the Initial Treatment of Advanced Ovarian and Primary Peritoneal Carcinoma
  ClinicalTrials.gov Identifier: NCT00193297 - Active, not recruiting
  Ovary Cancer
  
• Polyglutamate Paclitaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer
  ClinicalTrials.gov Identifier: NCT00060359 - Active, not recruiting
  Fallopian Tube Cancer; ovarian epithelial cancer; peritoneal cavity cancer
  
• Paclitaxel, Carboplatin and Radiotherapy as Induction Therapy in Locally Advanced Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00176254 - Active, not recruiting
  Squamous Cell Carcinoma
  
• A Study of Carboplatin + Paclitaxel and MK0683 in Patients With Chemotherapy-Naive Non-Small Cell Lung Cancer (NSCLC)
  ClinicalTrials.gov Identifier: NCT00424775 - Active, not recruiting
  Neoplasms
  
• Evaluation of Carboplatin Plus Gemcitabine Followed by Concomitant Chemoradiation for Non-Resectable Stage III NSCLC
  ClinicalTrials.gov Identifier: NCT00463515 - Active, not recruiting
  Non-Small-Cell-Lung Cancer
  
• Paclitaxel and Carboplatin in Treating Patients With Locally Advanced or Metastatic Renal Cell Cancer
  ClinicalTrials.gov Identifier: NCT00077129 - Active, not recruiting
  stage III renal cell cancer; Stage IV Renal Cell Cancer; recurrent renal cell cancer
  
• Gefitinib With or Without Carboplatin and Paclitaxel in Treating Older Patients With Unresectable or Metastatic Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00062062 - Active, not recruiting
  stage IV non-small cell lung cancer; stage IIIB non-small cell lung cancer
  
• Cisplatin and Irinotecan Followed by Carboplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00072527 - Active, not recruiting
  limited stage small cell lung cancer
  
• Docetaxel and Trastuzumab With or Without Carboplatin in Treating Women With HER2-Positive Breast Cancer
  ClinicalTrials.gov Identifier: NCT00047255 - Active, not recruiting
  stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer; recurrent breast cancer
  
• Paclitaxel and Carboplatin With or Without BMS-275291 in Treating Patients With Advanced or Metastatic Non-small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00006229 - Active, not recruiting
  stage IV non-small cell lung cancer; stage IIIB non-small cell lung cancer
  
• Paclitaxel, Carboplatin And Low Dose Radiation As Induction Therapy In Locally Advanced Head And Neck Cancer
  ClinicalTrials.gov Identifier: NCT00176267 - Active, not recruiting
  Squamous Cell Carcinoma
  
• Randomized Ph 2 Trial Of Paclitaxel/Carboplatin /Bevacizumab + PF-3512676 And P/C/B Alone In Advanced Nonsquamous NSCLC
  ClinicalTrials.gov Identifier: NCT00313768 - Active, not recruiting
  Carcinoma, Non-Small-Cell Lung
  
• Carboplatin and Etoposide With or Without Thalidomide in Treating Patients With Limited-Stage or Extensive-Stage Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00061919 - Active, not recruiting
  extensive stage small cell lung cancer; limited stage small cell lung cancer
  
• Carboplatin, Temozolomide, and Filgrastim in Treating Patients With Newly Diagnosed or Recurrent High-Grade Glioma
  ClinicalTrials.gov Identifier: NCT00006263 - Active, not recruiting
  adult brain stem glioma; adult glioblastoma multiforme; high-grade childhood cerebral astrocytoma; adult anaplastic astrocytoma; ...
  
• Celecoxib, Paclitaxel, and Carboplatin in Treating Patients With Cancer of the Esophagus
  ClinicalTrials.gov Identifier: NCT00066716 - Active, not recruiting
  Adenocarcinoma of the Esophagus; squamous cell carcinoma of the esophagus; stage I esophageal cancer; stage II esophageal cancer; ...
  
• Study of Paclitaxel, Carboplatin, and Cetuximab for Advanced Lung Cancer
  ClinicalTrials.gov Identifier: NCT00315185 - Active, not recruiting
  Carcinoma, Non-Small-Cell Lung
  
• Carboplatin Plus Vincristine in Treating Children and Adolescents With Low Grade Glioma
  ClinicalTrials.gov Identifier: NCT00003015 - Active, not recruiting
  untreated childhood visual pathway glioma; low-grade childhood cerebral astrocytoma; untreated childhood cerebellar astrocytoma; ...
  
• Carboplatin, Vincristine, and Temozolomide in Treating Children With Progressive and/or Symptomatic Low-Grade Glioma
  ClinicalTrials.gov Identifier: NCT00077207 - Active, not recruiting
  untreated childhood cerebellar astrocytoma; untreated childhood visual pathway and hypothalamic glioma; childhood spinal cord tumors; ...
  
• Gemcitabine, Carboplatin, and Bortezomib in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00075751 - Active, not recruiting
  stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer; recurrent non-small cell lung cancer
  
• Doxorubicin, Paclitaxel, and Carboplatin in Treating Patients With Primary Stage III, Stage IV, or Recurrent Endometrial Cancer
  ClinicalTrials.gov Identifier: NCT00006377 - Active, not recruiting
  stage III endometrial cancer; stage IV endometrial cancer; recurrent endometrial cancer
  
• Weekly Paclitaxel, Low-Dose Estramustine, and Carboplatin in the Treatment of Hormone Refractory Prostate Carcinoma
  ClinicalTrials.gov Identifier: NCT00193193 - Active, not recruiting
  Prostate Cancer
  
• Ifosfamide/Carboplatin/Etoposide/Rituxan Followed by Zevalin in Relapsed/Refractory Intermediate Grade B-Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00193505 - Active, not recruiting
  Non-Hodgkins Lymphoma
  
• Lenalidomide, Docetaxel, and Carboplatin in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00415116 - Active, not recruiting
  Unspecified Adult Solid Tumor, Protocol Specific
  
• Carboplatin and Gemcitabine Combined With Celecoxib and/or Zileuton in Treating Patients With Advanced Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00070486 - Active, not recruiting
  stage IV non-small cell lung cancer; Adenocarcinoma of the Lung; Squamous Cell Lung Cancer; large cell lung cancer; ...
  
• Radiation Therapy and Paclitaxel, Carboplatin, and Fluorouracil Followed by Esophagectomy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
  ClinicalTrials.gov Identifier: NCT00022139 - Active, not recruiting
  stage III gastric cancer; stage II esophageal cancer; stage III esophageal cancer; adenocarcinoma of the stomach; ...
  
• Carboplatin With or Without Liposomal Doxorubicin in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00043082 - Active, not recruiting
  peritoneal cavity cancer; recurrent ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer
  
• Vorinostat, Paclitaxel, and Carboplatin in Treating Patients With Advanced or Refractory Solid Tumors
  ClinicalTrials.gov Identifier: NCT00287937 - Active, not recruiting
  Unspecified Adult Solid Tumor, Protocol Specific
  
• Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
  ClinicalTrials.gov Identifier: NCT00107510 - Active, not recruiting
  stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; Male Breast Cancer
  
• Flavopiridol Plus Cisplatin or Carboplatin in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00003690 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer; stage IV prostate cancer; recurrent prostate cancer; Stage IV Melanoma; Recurrent Melanoma; ...
  
• Paclitaxel and Carboplatin in Treating Women Who are Undergoing Surgery for Newly Diagnosed, Locally Advanced Breast Cancer
  ClinicalTrials.gov Identifier: NCT00096343 - Active, not recruiting
  invasive ductal breast carcinoma; invasive lobular breast carcinoma; stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; ...
  
• Study of Carboplatin/Gemcitabine Plus Bevacizumab in Advanced Lung Cancer
  ClinicalTrials.gov Identifier: NCT00150657 - Recruiting
  Non-small cell lung cancer
  
• An Open Label Study in Patients With Advanced NSCLC With ABI-007(Abraxane) in Combination With Carboplatin
  ClinicalTrials.gov Identifier: NCT00274443 - Active, not recruiting
  Non-Small Cell Lung Cancer (NSCLC)
  
• Docetaxel and Carboplatin in Treating Patients With Recurrent Stage IVB Squamous Cell Carcinoma (Cancer) of the Cervix
  ClinicalTrials.gov Identifier: NCT00084890 - Active, not recruiting
  stage IVB cervical cancer; recurrent cervical cancer; cervical squamous cell carcinoma
  
• Radiation Therapy, Pemetrexed Disodium, and Carboplatin in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00268437 - Active, not recruiting
  Adenocarcinoma of the Esophagus; Squamous Cell Carcinoma of the Esophagus; Stage III Esophageal Cancer; Stage II Esophageal Cancer
  
• Carboplatin, Paclitaxel, and Radiation Therapy With or Without Thalidomide in Treating Patients With Stage III Non-small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00004859 - Active, not recruiting
  Adenocarcinoma of the Lung; Adenosquamous Cell Lung Cancer; Bronchoalveolar Cell Lung Cancer; large cell lung cancer; Non-small cell lung cancer; ...
  
• Docetaxel and Carboplatin With or Without Zoledronate in Treating Patients With Unresectable Stage IIIB or Stage IV Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00093717 - Active, not recruiting
  Adenocarcinoma of the Lung; large cell lung cancer; Squamous Cell Lung Cancer; stage IIIB non-small cell lung cancer; ...
  
• Carboplatin, Paclitaxel and TLK286 (Telcyta) as First-Line Therapy in Advanced Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00088556 - Recruiting
  Carcinoma, Non-Small-Cell Lung
  
• Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00288041 - Active, not recruiting
  Intraocular Melanoma; Melanoma (Skin)
  
• STA-4783 in Combination with Paclitaxel and Carboplatin for the Treatment of Chemotherapy Naive Patients with Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)
  ClinicalTrials.gov Identifier: NCT00088088 - Active, not recruiting
  stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer
  
• Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Metastatic Solid Tumors
  ClinicalTrials.gov Identifier: NCT00520000 - Active, not recruiting
  Unspecified Adult Solid Tumor, Protocol Specific
  
• Vinorelbine, Gemcitabine, and Docetaxel Compared With Paclitaxel and Carboplatin in Treating Patients With Advanced Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00079287 - Active, not recruiting
  Adenocarcinoma of the Lung; large cell lung cancer; recurrent non-small cell lung cancer; Squamous Cell Lung Cancer; ...
  
• Chemotherapy in Treating Patients With Retinoblastoma
  ClinicalTrials.gov Identifier: NCT00002675 - Active, not recruiting
  Retinoblastoma
  
• Paclitaxel With or Without Carboplatin in Treating Patients With Advanced Non-small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00003117 - Active, not recruiting
  stage IIIB non-small cell lung cancer; recurrent non-small cell lung cancer; stage IV non-small cell lung cancer; Adenosquamous Cell Lung Cancer; ...
  
• Paclitaxel and Carboplatin Chemotherapy Compared With Standard Chemotherapy in Treating Patients With Stage III or Stage IV Non-small Cell Lung Cancer That Cannot Be Removed During Surgery
  ClinicalTrials.gov Identifier: NCT00004887 - Active, not recruiting
  stage IIIA non-small cell lung cancer; stage IV non-small cell lung cancer; stage IIIB non-small cell lung cancer
  
• Paclitaxel and Carboplatin in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00049257 - Recruiting
  adenocarcinoma of the prostate; recurrent prostate cancer; stage IV prostate cancer
  
• Carboplatin, Paclitaxel, and Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed During Surgery
  ClinicalTrials.gov Identifier: NCT00003387 - Active, not recruiting
  Squamous Cell Lung Cancer; stage III non-small cell lung cancer; Adenocarcinoma of the Lung; large cell lung cancer
  
• Hospitalization Rates of Patients With Non-Small Cell Lung Cancer Treated With Gemcitabine and Either Cisplatin or Carboplatin
  ClinicalTrials.gov Identifier: NCT00055965 - Active, not recruiting
  stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer
  
• Trastuzumab, Docetaxel, and Carboplatin in Treating Women with Stage II, Stage III, Or Inflammatory Breast Cancer
  ClinicalTrials.gov Identifier: NCT00118053 - Active, not recruiting
  inflammatory breast cancer; stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer
  
• Combined Phase I/II Study of Epirubicin (Pharmorubicin®), Carboplatin (Paraplatin®) and Capecitabine (Xeloda®) (ECC) in the Treatment of Unresectable Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Cancer with Pharmacogenet
  ClinicalTrials.gov Identifier: NCT00130936 - Recruiting
  -gastric cancer; -esophageal cancer; -solid tumors
  
• Carboplatin Combined with Paclitaxel in Treating Patients With Advanced Thymoma
  ClinicalTrials.gov Identifier: NCT00010257 - Recruiting
  invasive thymoma and thymic carcinoma; recurrent thymoma and thymic carcinoma
  
• Irinotecan, Carboplatin and Radiation Therapy Followed by Bevacizumab in Limited Stage Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00193375 - Active, not recruiting
  Lung Cancer
  
• Docetaxel, Carboplatin, and Capecitabine as Treatment for Patients With Locally Advanced or Inflammatory Breast Cancer Before Surgery
  ClinicalTrials.gov Identifier: NCT00251329 - Active, not recruiting
  Breast Cancer